The bioautomation company emerges from stealth mode with investment led by Maverick Ventures and John Stuepelnagel (co-founder of Illumina) CAMBRIDGE, MA – Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced it raised $20 million in a Series A funding round. The round was led by Maverick […]
Tedia Announces Partnership with NewHold Enterprises Fairfield, OH & New York, NY, March 8, 2022 – Tedia Company, LLC (Tedia) today announced they have entered into a partnership with NewHold Enterprises, LLC (NewHold) through a strategic investment on March 4, 2022. Tedia is the largest manufacturer of OEM high-purity solvents in North America, selling its […]
CHARLOTTESVILLE, Va. — LumaCyte Corporation, a bioanalytical instrumentation leader in advanced label-free single-cell analytics, announced the successful completion of an A round financing that will allow the company to accelerate its global expansion efforts and service the increasing global demand of its flagship product, Radiance ®. LumaCyte will also use these funds to further expand the company’s […]
MOUNTAIN VIEW, Calif. — DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments. The round was led by funds […]
Milano (Italia), Santa Clara (California-USA) — Italgas strengthened its partnership with Picarro Inc. through the acquisition of a minority share of the US company, a leading technology start-up in the field of sensors applied to the monitoring of gas distribution networks, as well as in technologies designed for those sectors requiring extremely sensitive measurements, such […]
Cologne BioEcho Life Sciences GmbH, an innovative manufacturer of nucleic acid purification solutions for molecular diagnostics and life sciences research, today announced a minority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment will be used to support the company’s worldwide […]
ArgusEye has successfully completed its first external financing round, securing additional funding for further product development and team expansion. The strong investor syndicate in this oversubscribed funding round is led by Eir Ventures and ALMI Invest together with 10 life science experienced business angels. NY Consulting has provided strategic and financial advisory support during the […]
Strategic investment and partnership brings Spatial’s multiomics platform and seqFISH technology to Fulgent’s comprehensive suite of genomic testing solutions TEMPLE CITY, Calif. & PASADENA, Calif. — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today […]
Company Shows Another Year of Record Growth and Advancements STATE COLLEGE, Pa. — INDIGO Biosciences, Inc. (INDIGO), the recognized industry leader in nuclear receptor and in vitro toxicology testing solutions, has announced a record earnings year for 2021. INDIGO showed more than a 17% percent increase in revenue vs its previous record in 2019. “INDIGO provides […]
LONDON — Automata – the automation company helping life sciences rapidly innovate, diagnose and discover at scale – today announces it has raised US$50 million in Series B funding. The investment round was led by Octopus Ventures with participation from returning investors Hummingbird, Latitude Ventures, ABB Technology Ventures, Isomer Capital as well as strategic investors such as In-Q-Tel, amongst others. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
